Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Philadelphia, Pennsylvania 19107


Purpose:

The main goal of the study is to compile a normative database for the Neuro Optic Vision Assessment (NOVATM) Pattern Electroretinogram (PERG) and Flash Electroretinogram (FERG) modules. This normalization intends to be included in a probabilistic analysis protocol to allow NOVATM PERG/FERG users to identify patients with results outside the normal ranges.


Study summary:

Investigators plan to enroll 50 subjects at Wills Eye Hospital without any eye diseases. Participants will undergo a complete eye examination to determine eligibility, including visual acuity testing, intraocular pressure (IOP) in millimeters of mercury (mmHG), and visual field (VF) testing. Participants will then be tested with Diopsys NOVA™ PERG & FERG systems. For both tests, two electrodes are placed on the skin underneath each eye below the eyelashes. Participants' skin will be cleaned before electrodes are placed. A small amount of gel will be placed on skin where electrodes are placed for testing. Electrical responses are recorded with electrodes in response to visual stimuli.


Criteria:

Inclusion Criteria: - Healthy volunteers age 18 years - older with normal eye exam Exclusion Criteria: - spherical refraction outside + 5.0 Diopters and cylinder correction outside + 3.0 Diopters. - IOP (intraocular pressure) ≥ 22 mm Hg (millimeters of mercury) - history of any type of glaucoma in either eye. - Intraocular surgery in study eye (except non-complicated cataract or refractive surgery performed more than 1 year before enrollment). - Best corrected visual acuity worse than 20/40. - Evidence of diabetic retinopathy, diabetic macular edema, or other vitreo-retinal disease in either eye. - Evidence of optic nerve, macula and/or retinal nerve fiber layer abnormality in either eye. - Evidence of reproducible (false positives, fixation losses and false negatives ≤ 25% with no observable testing artifacts). - Standard Automatic Perimetry (SAP) abnormality in either eye, defined as Pattern Standard Deviation < 5% level, and/or abnormal Glaucoma Hemifield test result, and/or any other pattern of loss which is consistent with a neurologic and/or ocular disease. - Current or recent (within the past 30 days) use of an agent (by any administering method) known to affect visual function. - Inability to obtain reliable PERG/FERG (Pattern Electroretinogram/Flash Electroretinogram) results.


NCT ID:

NCT02609204


Primary Contact:

Principal Investigator
L. Jay Katz, MD
Wills Eye Hospital


Backup Contact:

N/A


Location Contact:

Philadelphia, Pennsylvania 19107
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: November 18, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.